Pre-adjuvant chemotherapy leukocyte count may predict the outcome for advanced gastric cancer after radical resection
详细信息    查看全文
文摘
Gastric cancer (GC) has a high morbidity worldwide each year especially in China and advanced GC is well known with poor prognosis, for which surgical resection combine adjuvant chemotherapy is the optimal choice for therapy. Leukocyte is an important index during the treatment for its influence on drugs鈥?dosage and tolerance. Therefore, peripheral blood leukocyte and its subsets during adjuvant chemotherapy may have great clinical value for predicting prognostic. In this retrospective study, we showed the distribution of white blood cell and its subsets in the baseline period before adjuvant chemotherapy in 399聽patients who underwent radical resection for advanced GC from January 1, 2008 to August 31, 2012. We investigated the relationship between leukocyte count and overall survival (OS) as well as disease-free survival (DFS). In these patients, females were more likely to have less white blood cells after operation (P = 0.016). Patients with pre-chemotherapy leukocyte count less than 4 脳 109/L got worse DFS (P = 0.028) and OS (P = 0.016). In multivariate analysis, tumor size 鈮?6 cm (P = 0.033), TNM stage IV (P = 0.024), vascular or nerval invasion (P = 0.005) and leukocyte count less than 4.0 脳 109/L (P = 0.019) was associated with poor DFS. TNM stage IV (P = 0.008), vascular or nerval invasion (P = 0.001) and lower leukocyte count (P = 0.045) were independent risk factors for poor OS. Taken together, our findings suggest that pre-adjuvant chemotherapy peripheral blood leukocyte count correlates with clinical outcome of patients with advanced GC after radical resection.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700